Spebrutinib
Spebrutinib has been used in trials studying the treatment of Rheumatoid Arthritis, Lymphoma, Large B-Cell, Diffuse, and Leukemia Lymphocytic Chronic B-Cell. Reference standards of Spebrutinib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => Spebrutinib - API Standards
[catalogue_number] => PA 19 1730000
[category_ids] => ,123,81,75,76,78,70,82,
[chemical_name] =>
[weight] => 423.45
[form] => C22H22FN5O3
[cas] => 1202757-89-8
[pslug] => 1202757-89-8-spebrutinib-api-pa191730000
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Spebrutinib - API Standards
Catalogue No.:PA 19 1730000
Molecular Formula : C22H22FN5O3
Molecular Weight : 423.45
stdClass Object
(
[pname] => 4-[[4-[[6-(Acryloyloxy)hexyl]oxy]benzoyl]oxy]phenyl 4-[(8-hydroxyoctyl)oxy]benzoate
[catalogue_number] => PA 19 1731000
[category_ids] => ,123,81,75,76,78,70,82,
[chemical_name] =>
[weight] => 632.75
[form] => C37H44O9
[cas] => 1353567-91-5
[pslug] => 1353567-91-5-4-4-6-acryloyloxy-hexyl-oxy-benzoyl-oxy-phenyl-4-8-hydroxyoctyl-oxy-benzoate-pa191731000
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
4-[[4-[[6-(Acryloyloxy)hexyl]oxy]benzoyl]oxy]phenyl 4-[(8-hydroxyoctyl)oxy]benzoate
Catalogue No.:PA 19 1731000
Molecular Formula : C37H44O9
Molecular Weight : 632.75